Table 1 Relationship between PSMC2 expression and clinical characteristics in patients with skin cutaneous melanoma.
From: PSMC2 knockdown suppressed tumor progression of skin cutaneous melanoma
Features | No. of cases | PSMC2 expression | high | p value |
|---|---|---|---|---|
low | ||||
All cases | 105 | 60 | 45 | |
Age (years) | 0.104 | |||
≤ 54 | 54 | 35 | 19 | |
å 54 | 51 | 25 | 26 | |
Gender | 0.611 | |||
Male | 59 | 35 | 24 | |
Female | 46 | 25 | 21 | |
T Infiltrate | 0.074 | |||
T2 | 6 | 3 | 3 | |
T3 | 28 | 12 | 16 | |
T4 | 71 | 45 | 26 | |
lymphatic metastasis (N) | 0.000*** | |||
N0 | 91 | 60 | 31 | |
N1 | 10 | 0 | 10 | |
N2 | 4 | 0 | 4 | |
Stage | 0.000*** | |||
I | 6 | 3 | 3 | |
II | 83 | 57 | 26 | |
III | 12 | 0 | 12 | |
IV | 4 | 0 | 4 |
